[Consensus of Chinese expert on the diagnosis and treatment of hemophilia (version 2017)]
- PMID: 28565732
- PMCID: PMC7354196
- DOI: 10.3760/cma.j.issn.0253-2727.2017.05.002
[Consensus of Chinese expert on the diagnosis and treatment of hemophilia (version 2017)]
Similar articles
-
[Chinese guidelines on the treatment of hemophilia (version 2020)].Zhonghua Xue Ye Xue Za Zhi. 2020 Apr 14;41(4):265-271. doi: 10.3760/cma.j.issn.0253-2727.2020.04.001. Zhonghua Xue Ye Xue Za Zhi. 2020. PMID: 32295333 Free PMC article. Chinese. No abstract available.
-
[Chinese expert consensus on the diagnosis and treatment of acquired hemophilia A].Zhonghua Xue Ye Xue Za Zhi. 2014 Jun;35(6):575-6. doi: 10.3760/cma.j.issn.0253-2727.2014.06.026. Zhonghua Xue Ye Xue Za Zhi. 2014. PMID: 24985192 Review. Chinese. No abstract available.
-
[The RFLPs of St14/Taq I in Chinese and its application to gene analysis and prenatal diagnosis of hemophilia A].Yi Chuan Xue Bao. 1989;16(4):325-30. Yi Chuan Xue Bao. 1989. PMID: 2577235 Chinese.
-
[Consensus of Chinese experts on diagnosis and treatment of hemophilia].Zhonghua Xue Ye Xue Za Zhi. 2011 Mar;32(3):212-3. Zhonghua Xue Ye Xue Za Zhi. 2011. PMID: 21535968 Chinese. No abstract available.
-
The Chinese Association for the Study of Pain (CASP): Expert Consensus on the Cervicogenic Headache.Pain Res Manag. 2019 Apr 1;2019:9617280. doi: 10.1155/2019/9617280. eCollection 2019. Pain Res Manag. 2019. PMID: 31065305 Free PMC article. Review.
Cited by
-
[Expert recommendations on homogenization management of the diagnosis and treatment of rare diseases in children].Zhongguo Dang Dai Er Ke Za Zhi. 2023 Jul 15;25(7):663-671. doi: 10.7499/j.issn.1008-8830.2304036. Zhongguo Dang Dai Er Ke Za Zhi. 2023. PMID: 37529946 Free PMC article. Chinese.
-
Sequential combined bypassing therapy in haemophilia patients with high titer inhibitors: surgical experience.Ann Hematol. 2025 Mar;104(3):1949-1960. doi: 10.1007/s00277-025-06265-6. Epub 2025 Feb 26. Ann Hematol. 2025. PMID: 40009167 Free PMC article.
-
The effect of prophylactic FVIII infusion combined with personalized rehabilitation on joint health and quality of life in children with hemophilia.Front Pediatr. 2025 Jul 10;13:1578617. doi: 10.3389/fped.2025.1578617. eCollection 2025. Front Pediatr. 2025. PMID: 40708907 Free PMC article.
-
Medical costs and hospital utilization for hemophilia A and B urban inpatients in China: a national cross-sectional study.BMC Health Serv Res. 2022 Feb 19;22(1):230. doi: 10.1186/s12913-022-07626-x. BMC Health Serv Res. 2022. PMID: 35183186 Free PMC article.
-
Pharmacokinetic parameter driven outcomes model predicts a reduction in bleeding events associated with BAY 81-8973 versus antihemophilic factor (recombinant) plasma/albumin-free method in a Chinese healthcare setting.BMC Med Res Methodol. 2022 Aug 5;22(1):215. doi: 10.1186/s12874-022-01659-w. BMC Med Res Methodol. 2022. PMID: 35931967 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical